Ptc Therapeutics (PTCT) Amortizatization of Intangibles (2014 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly Amortizatization of Intangibles of $4.1 million in Q1 2026, up 124.56% quarter-over-quarter from $1.8 million in Q4 2025, and up 77.86% on a YoY basis from $2.3 million in Q1 2025.
Ptc Therapeutics (PTCT) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
Ptc Therapeutics' Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 77.86% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $9.3 million (down 28.98% YoY), while the FY2025 annual figure was $7.5 million, down 40.4% from the prior year.
- Amortizatization of Intangibles was $4.1 million for Q1 2026 at Ptc Therapeutics, up from $1.8 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $8.1 million in Q3 2023 to a low of -$6.1 million in Q3 2022.
- Historically, Amortizatization of Intangibles has averaged $1.4 million across 5 years, with a median of $1.9 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles sank 7639.24% in 2023, then jumped 282.24% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $79000.0 in 2022, then tumbled by 7639.24% to -$6.0 million in 2023, then surged by 205.05% to $6.3 million in 2024, then slumped by 70.72% to $1.8 million in 2025, then soared by 124.56% to $4.1 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $4.1 million (Q1 2026), $1.8 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | 4.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.11 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | -1.23 Mn |
| Sep 30, 2025 | -1.23 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 6.26 Mn |
| Dec 31, 2024 | 6.26 Mn |
| Sep 30, 2024 | -721,000.00 |
| Sep 30, 2024 | -721,000.00 |
| Jun 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Mar 31, 2024 | 1.79 Mn |
| Mar 31, 2024 | 1.79 Mn |
| Dec 31, 2023 | -5.96 Mn |
| Dec 31, 2023 | -5.96 Mn |